18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma

• Published in: Journal of otolaryngology 2022-04, Vol.51 (1), p.13-13
• Main Authors: Suzuki, Shinsuke, Toyoma, Satoshi, Abe, Tomoe, Endo, Tentaro, Kouga, Teppei, Kaswasaki, Yohei, Yamada, Takechiyo
• Format: Article
• Language: English
• Subjects: 18F-FDG-PET/CT; Analysis; Cable television broadcasting industry; Cancer therapies; Chemotherapy; CT imaging; Disease-Free Survival; Distant metastasis; Fluorodeoxyglucose F18; Head & neck cancer; Head and Neck Neoplasms; Humans; Hypopharyngeal squamous cell carcinoma; Larynx; Maximum standardized uptake value; Medical prognosis; Medical research; Medicine, Experimental; Metastasis; Multivariate analysis; Original; Otolaryngology; Patients; PET imaging; Positron Emission Tomography Computed Tomography - methods; Prognosis; Radiation therapy; Squamous cell carcinoma; Squamous Cell Carcinoma of Head and Neck - diagnostic imaging; Surgery; Survival; Survival analysis; Throat cancer; Tomography; Tumors
• ISSN: 1916-0216; 1916-0208; 1916-0216
• DOI: 10.1186/s40463-022-00568-8

Hypopharyngeal squamous cell carcinoma (HPSCC) has a high rate of distant metastasis, resulting in poor prognosis. The role of the maximum standardized uptake value (SUVmax), which was assessed via pretreatment 18-fluorodeoxyglucose positron emission tomography (FDG-PET), and computed tomography (CT) was examined, for predicting distant metastasis and survival. This study included 121 patients who underwent pretreatment FDG-PET/CT scanning and subsequent treatment for HPSCC. The SUVmax was measured via FDG-PET/CT. A receiver operating characteristic (ROC) curve analysis was used to determine whether the SUVmax was a predictor of distant metastasis and to select the best cutoff value. Univariate and multivariate Cox hazard regression analyses were used in identifying associations between the SUVmax and other clinicopathological factors with distant metastasis-free survival. Distant metastases were identified in 33 patients during the median follow-up of 24 months after treatment. The ROC curve analysis determined that SUVmax was predictive of distant metastasis and identified a SUVmax of 13.9 as the best potential cutoff value. The univariate analysis showed that T and N classification, clinical stage, and SUVmax were significantly related to distant metastasis. However, in multivariate analysis, an SUVmax ≥ 13.9 was the only independent predictor of distant metastasis. Patients with high SUVmax values displayed significantly shorter distant metastasis-free survival and overall survival. SUVmax determined via pretreatment FDG-PET/CT is useful for predicting distant metastasis, distant metastasis-free survival, and overall survival in patients with HPSCC.